Biocept, Inc. Announces Closing Of Initial Public Offering

Published: Feb 11, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, Feb. 10, 2014 (GLOBE NEWSWIRE) -- Biocept, Inc. (Nasdaq:BIOC), an oncology diagnostics company focused on improving individual patient treatment, announced today the closing of its previously announced initial public offering of 1,900,000 shares of common stock, at a public offering price of $10.00 per share. The gross proceeds to Biocept from the offering were $19,000,000, before deducting underwriting discounts and commissions and other offering expenses payable by Biocept.

Help employers find you! Check out all the jobs and post your resume.

Back to news